Signaling Pathways - Insulin and Insulin-like Receptors - Quinone reductase - Sphingosine kinases (SphKs) - Reverse Transcriptases
清除全部
- B2224 Etravirine (TMC125)中文名: 依曲韦林Target: Reverse TranscriptasesSummary: 逆转录酶抑制剂
- B2223 Zalcitabine中文名: 扎西他滨Target: Reverse TranscriptasesSummary: 逆转录酶抑制剂
- B1298 K145Target: Sphingosine kinases (SphKs)Summary: SphK2抑制剂
- B2226 SKI IITarget: Sphingosine kinases (SphKs)Summary: 鞘氨醇激酶(SK)抑制剂
- A8554 Dapivirine (TMC120)中文名: 达匹维林Target: Reverse TranscriptasesSummary: 非核苷逆转录酶抑制剂
- A8422 Emtricitabine1 Citation中文名: 恩曲他滨Target: Reverse TranscriptasesSummary: 逆转录酶抑制剂
- A8410 Didanosine中文名: 去羟肌苷Target: Reverse TranscriptasesSummary: 逆转录酶抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂